CTGCT
  • en
    • si
  • About us
    • About CTGCT
    • Partners
    • CTGCT Days 2025
    • Funding of the CTGCT
  • Job Openings
  • Products and Services
  • Learning Box
    • Learning Box
    • CTGCT Science Talks
    • Publications
  • POSTS
    • Events
    • Articles
    • News
    • All posts
  • Get in touch

Gen Therapy

  • Events
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Business Model
  • Drug Discovery
  • Economics
  • Investment
  • Marketaccess
  • Regulation
  • Research
  • CTGCT
  • Gregor Cuzak
12 September 2024 Event Date: 6 September 2024 • 09:00 do: 6 September 2024 •

European Commission Hosts Sixth Regional HTA Event in Budapest

The European Commission recently held its sixth regional event in Budapest, focusing on the upcoming Health Technology Assessment (HTA) regulation. Set to launch in January 2025, this new framework aims to streamline the evaluation ...

Hta 20230511 Banner 0
  • Articles
  • Pacients
  • Researchers
  • Cell therapy
  • Gen Therapy
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
30 August 2024

Exciting news in Sonogenetics: A New Frontier for Deep Tissue Treatment

Researchers have made a discovery that could change how we treat some diseases deep within the human body. This technique, known as sonogenetics, combines the power of ultrasound with genetically engineered cells to deliver ...

Graphical Abstract Sonogenetics
  • Events
  • Clinicians
  • Researchers
  • Gen Therapy
  • Drug Discovery
  • Research
  • CTGCT
  • NIC
  • Gregor Cuzak
17 July 2024

CTGCT about on/off switching of CAR-Ts at the EBMT 2024

Assoc. Prof Dr Mojca Benčina, head of the newly founded Slovenian Centre for the Technologies of Gene and Cell Therapy (CTGCT), gave a speech at the recent 50th Annual Meeting of the European Society ...

Featured Up Regulation
  • Clinicians
  • Researchers
  • Cell therapy
  • Gen Therapy
  • GMP
  • Business Model
  • Clinic study
  • Drug Discovery
  • Economics
  • Investment
  • Logistics
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • UCL
  • Gregor Cuzak
17 July 2024

UCL ATMP Pipeline

Our partner University College London (UCL) have produced a great short brochure (link) showing the strength and depth  of their pipeline of ATMPs. They use a managed portfolio approach in which they support ~100 ...

Pipeline By Number Of Projects
  • Events
  • Clinicians
  • Researchers
  • Cell therapy
  • Gen Therapy
  • GMP
  • Clinic study
  • Marketaccess
  • Regulation
  • Research
  • Charite Berlin
  • CTGCT
  • NIC
  • UMCUtrecht
  • Gregor Cuzak
1 July 2024

Panel Discussion on ATMP Regulation

The CTGCT organised its first Panel Discussion on 29 May entitled: ATMP Regulation. The main takeaway from the very successful session was that the strong potential of the Slovenian ecosystem requires the will to ...

  • Events
  • Clinicians
  • Pacients
  • Researchers
  • Gen Therapy
  • GMP
  • Clinic study
  • Datamanagement
  • Drug Discovery
  • Ethicalcommittee
  • Investment
  • Laboratory
  • Logistics
  • Manufacturing Process
  • Modalitetadelovanjazdravila
  • Pharmacodynamics
  • Pharmacokinetics
  • Pre Clinical
  • Raw Material
  • Regulation
  • Research
  • CTGCT
  • NIC
  • Gregor Cuzak
26 June 2024 Event Date: 14 June 2024 • 09:00 − 17:00

CTNNB1 Conference – One Year to Cure

One year to cure is the goal shared by parents of children with the CTNNB1 Syndrome rare disease. Out of approximately 400 known cases worldwide, 82 families with children gathered at the conference in ...

Posts pagination

1 2 3

Logo Foot

Center for the Technologies of Gene and Cell Therapies (CTGCT) is an infrastructure center  within the National Institute of Chemistry, Slovenia

Contact

  • +386 1 4760 335
  • info@ctgct.si
  • Hajdrihova 19, 1001 Ljubljana

Privacy policy

  • Cookies

Follow us

X Twitter Brands SolidX-twitter

LinkedIn

Bluesky Brands Solid Bluesky

Funding

 

Eu Logo

Ukri Logo

Ifeelslovenia Logo 400

Project: 101059842 – CTGCT – HORIZON-WIDERA-
Co-funded by the European Union, this project has received funding from Horizon Europe (grant agreement No. 101059842) and European Regional Development Fund EU under Slovenia’s Cohesion Policy Programme 2021-2027 (grant agreement No. C3360-25-952005) and the UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee (grant number 10069462). Views and opinions expressed are of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Commission nor the granting authority can be held responsible for them.


CTGCT © 2026
Website production: Kreativna tovarna